ClinicalTrials.Veeva

Menu

Effectiveness of Programed Intermittent Epidural Bolus Interval 90 (EI90) of 10 ml, 0.0625% Bupivacaine Plus 2 μg/mL Fentanyl interval90(EI90)of10ml,0.0625%Bupivacaine Plus 2μg/mL Fentanyl

M

Menoufia University

Status

Completed

Conditions

Labour Pain

Treatments

Device: programed intermittent epidural bolus interval 90 (EI90)

Study type

Interventional

Funder types

Other

Identifiers

NCT05441085
ANET2022

Details and patient eligibility

About

Multiple studies showed the numerous advantages of implementing programmed epidural bolus (PIEB) technique, where a fixed volume of local anesthetic is automatically administrated at a set time interval compared to the continuous epidural infusion technique (CEI). The advantages were improved maternal satisfaction, decreased local anesthetic consumption, and decreased second stage of labor.The theory behind PIEB is that to attain a more uniform spread of local anesthetic in the epidural space a higher volume of injectate and a higher pressure is needed.Different approaches using different timings and volumes for PIEB have been proposed to achieve the optimal regimen. Many studies showed evidence that 10 mL boluses of bupivacaine 0.0625% with fentanyl 2 μg/mL delivered every 40 min, named effective programed intermittent epidural bolus interval 90 (EI90), produced effective analgesia without breakthrough pain in 90% of nulliparous women during the first stage of labor.

Enrollment

30 patients

Sex

Female

Ages

Under 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients of ASA physical status 2-3 with a singleton pregnancy
  • gestational age > 37 weeks
  • regular uterine contractions occurring at least every 5 min;
  • cervical dilation 2-5 cm
  • pain > 5 (Visual analogue score (VAS) 0-10) at the time of request for epidural analgesia .

Exclusion criteria

  • Refusal to concent
  • Contraindication to epidural analgesia as allergy or hypersensitivity to bupivacaine or fentanyl
  • Patients who had opioids or sedatives within 4 h preceding epidural insertion.
  • Unintentional dural puncture.
  • Patient who deliver within 1 h after initiation of epidural clinician bolus.
  • The inability to achieve as VAS score ≤2 after the initial loading dose will be considered as a failure and will be excluded from the study.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

Nulliparous
Active Comparator group
Description:
Patients of ASA physical status 2-3 with a singleton pregnancy; gestational age > 37 weeks; regular uterine contractions occurring at least every 5 min; cervical dilation 2-5 cm; and pain > 5
Treatment:
Device: programed intermittent epidural bolus interval 90 (EI90)
Multiparous
Active Comparator group
Description:
Patients of ASA physical status 2-3 with a singleton pregnancy; gestational age > 37 weeks; regular uterine contractions occurring at least every 5 min; cervical dilation 2-5 cm; and pain > 5
Treatment:
Device: programed intermittent epidural bolus interval 90 (EI90)

Trial contacts and locations

2

Loading...

Central trial contact

Rabab Mohammed Habeeb

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems